Dr. Reddy's Laboratories Company Profile (NYSE:RDY)

About Dr. Reddy's Laboratories

Dr. ReddyDr. Reddy's Laboratories Limited is an integrated global pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Global Generics segment consists of its business of manufacturing and marketing prescription and over-the-counter (OTC) finished pharmaceutical products, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients (API) and intermediates. Proprietary Products segment consists of its differentiated formulations business, its new chemical entities (NCEs) business and its dermatology focused specialty business. The Company's OTC brands include Doan's, Bufferin, Nupercainal Ointment, Cruex Nail Gel, Comtrex and Myoflex.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: RDY
  • CUSIP:
Key Metrics:
  • Previous Close: $45.61
  • 50 Day Moving Average: $47.51
  • 200 Day Moving Average: $46.47
  • 52-Week Range: $40.67 - $68.00
  • Trailing P/E Ratio: 35.20
  • Foreward P/E Ratio: 19.92
  • P/E Growth: 1.63
  • Market Cap: $7.66B
  • Outstanding Shares: 165,530,000
  • Beta: 0.87
Additional Links:
Companies Related to Dr. Reddy's Laboratories:

Analyst Ratings

Consensus Ratings for Dr. Reddy's Laboratories (NYSE:RDY) (?)
Ratings Breakdown: 4 Sell Ratings, 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 1.63)
Consensus Price Target: $41.90 (8.13% downside)

Analysts' Ratings History for Dr. Reddy's Laboratories (NYSE:RDY)
Show:
DateFirmActionRatingPrice TargetDetails
7/27/2016HSBCDowngradeHold -> ReduceView Rating Details
7/27/2016Jefferies GroupDowngradeHold -> Underperform$45.00 -> $41.90View Rating Details
7/26/2016Credit Suisse Group AGDowngradeNeutral -> UnderperformView Rating Details
5/2/2016Goldman Sachs Group Inc.Initiated CoverageNeutralView Rating Details
2/10/2016Credit Agricole SAUpgradeUnderperform -> BuyView Rating Details
12/2/2015Deutsche Bank AGInitiated CoverageSellView Rating Details
11/10/2015Citigroup Inc.DowngradeBuy -> NeutralView Rating Details
11/6/2015Barclays PLCDowngradeOverweight -> Equal WeightView Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for Dr. Reddy's Laboratories (NYSE:RDY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2016Q117$0.00$557.00 million$479.00 millionViewListenView Earnings Details
5/12/2016Q416$0.07$2.41 billion$567.00 billionViewListenView Earnings Details
2/9/2016Q316$0.51$2.48 million$599.00 millionViewN/AView Earnings Details
10/29/2015Q116$0.65$2.54 billionViewListenView Earnings Details
5/12/2015Q415$0.49$559.00 million$621.00 millionViewListenView Earnings Details
1/29/2015Q315$0.53$561.00 million$610.00 millionViewN/AView Earnings Details
7/30/2014Q115$0.54$474.00 million$486.00 millionViewN/AView Earnings Details
5/13/2014Q414$0.52$0.47$557.00 million$580.00 millionViewN/AView Earnings Details
2/11/2014Q314$0.45$0.59$558.20 million$571.00 millionViewN/AView Earnings Details
10/31/2013Q214$0.46$0.65$561.00 million$537.00 millionViewN/AView Earnings Details
7/30/2013Q413$0.43$0.40$551.40 million$478.00 millionViewN/AView Earnings Details
5/14/2013$0.60ViewN/AView Earnings Details
2/14/2013Q313$0.40$505.00 million$522.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dr. Reddy's Laboratories (NYSE:RDY)
Current Year EPS Consensus Estimate: $1.34 EPS
Next Year EPS Consensus Estimate: $2.29 EPS

Dividends

Current Dividend Information for Dr. Reddy's Laboratories (NYSE:RDY)
Annual Dividend:$0.28
Dividend Yield:0.61%
Dividend Growth:8.80% (3 Year Average)
Payout Ratio:21.05% (Based on Trailing 12 Months of Earnings)
20.90% (Based on Current Year Consensus EPS Estimate)
12.23% (Based on Next Year Consensus EPS Estimate)
Track Record:2 Years of Consecutive Dividend Growth

Dividend History for Dr. Reddy's Laboratories (NYSE:RDY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/6/2016Annual$0.287/14/20167/18/20167/18/2016
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Dr. Reddy's Laboratories (NYSE:RDY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Dr. Reddy's Laboratories (NYSE:RDY)
DateHeadline
News IconBuy Dr. Reddy's Laboratories Ltd., target Rs 3125.0 : Dr CK Narayan (NYSE:RDY)
economictimes.indiatimes.com - August 30 at 10:19 AM
News IconDr. Reddy's launches Nitroglycerin sublingual tablets in US (NYSE:RDY)
health.economictimes.indiatimes.com - August 29 at 6:50 PM
News IconDr. Reddy’s Laboratories launches heart drug in the US (NYSE:RDY)
rtn.asia - August 29 at 6:50 PM
News IconDr. Reddy's Laboratories Launches Nitroglycerin Sublingual Tablets USP in the U.S. ... (NYSE:RDY)
www.biomedreports.com - August 29 at 6:50 PM
seekingalpha.com logoDr. Reddy's launches generic nitroglycerin tablets in U.S. (NYSE:RDY)
seekingalpha.com - August 29 at 6:50 PM
rttnews.com logoDr. Reddy's Labs Launches Nitroglycerin Sublingual Tablets USP (NYSE:RDY)
www.rttnews.com - August 29 at 6:50 PM
streetinsider.com logoDr. Reddys Labs (RDY) Announces U.S. Launch of Generic Nitrostat Tabs (NYSE:RDY)
www.streetinsider.com - August 29 at 6:50 PM
News IconDr. Reddy's Laboratories Launches ... (NYSE:RDY)
www.advfn.com - August 29 at 6:50 PM
businesswire.com logoDr. Reddy's Laboratories Launches Nitroglycerin Sublingual Tablets ... - Business Wire (press release) (NYSE:RDY)
www.businesswire.com - August 29 at 11:37 AM
publicnow.com logoDr. Reddy's Laboratories launches Nitroglycerin sublingual tablets USP in the U.S. Market (NYSE:RDY)
www.publicnow.com - August 29 at 11:37 AM
mysmartrend.com logoLook for Shares of Dr Reddys Laboratories to Potentially Pullback after Yesterday's 1.23% Rise (NYSE:RDY)
www.mysmartrend.com - August 25 at 7:15 PM
investornewswire.com logoDr. Reddy's Laboratories Ltd (NYSE:RDY) Gets 1 Recommendations To Sell - Investor Newswire (NYSE:RDY)
www.investornewswire.com - August 24 at 6:48 PM
News IconDr Reddys Laboratories Ltd allots 77158 Equity Shares on exercise of ESOP (NYSE:RDY)
www.equitybulls.com - August 23 at 11:36 AM
News IconLupin, Sun Pharma, Cipla and Dr.Reddy's Laboratories top India's Most Reputed Pharmaceutical list (NYSE:RDY)
www.equitybulls.com - August 19 at 10:02 AM
marketrealist.com logoEfficient Policy Transmission in India Concerns the RBI (NYSE:RDY)
marketrealist.com - August 11 at 10:20 AM
marketrealist.com logoIndian Equities and Funds Fall after the August Monetary Policy (NYSE:RDY)
marketrealist.com - August 11 at 10:20 AM
ftsenews.co.uk logoDr. Reddy's Laboratories Ltd (NYSE:RDY) Updated Price Targets ... - FTSE News (NYSE:RDY)
www.ftsenews.co.uk - August 6 at 9:48 AM
News IconDr Reddys Laboratories Ltd completes acquisition of product portfolio from TEVA (NYSE:RDY)
www.equitybulls.com - August 5 at 10:07 AM
tradecalls.org logoHSBC Downgrades Dr.Reddy's Laboratories Ltd (ADR) to Reduce ... - Trade Calls (NYSE:RDY)
www.tradecalls.org - August 3 at 7:27 PM
finance.yahoo.com logoDr. Reddy’s Completes Acquisition of Product Portfolio from TEVA (NYSE:RDY)
au.finance.yahoo.com - August 3 at 7:27 PM
wsj.com logoHospital Chain’s CEO Faces Lawsuit Over Business Practices (NYSE:RDY)
www.wsj.com - August 1 at 7:30 AM
capitalcube.com logoETF’s with exposure to Dr. Reddy’s Laboratories Ltd. : July 29, 2016 (NYSE:RDY)
www.capitalcube.com - July 29 at 1:49 PM
fortune.com logoWhy Dr.Reddy's Laboratories Ltd (ADR) (NYSE:RDY) got downgraded? - Review Fortune (NYSE:RDY)
reviewfortune.com - July 28 at 7:23 PM
News IconSell Dr. Reddy's Laboratories., target Rs 2850: Manish Sharma (NYSE:RDY)
economictimes.indiatimes.com - July 28 at 10:19 AM
seekingalpha.com logoDr. Reddy's: Continues To Stumble. Longer-Term Thesis Intact (NYSE:RDY)
seekingalpha.com - July 28 at 10:19 AM
News IconHealthcare Investment Looking For Stocks- Tokai Pharmaceuticals (NASDAQ:TKAI), Dr. Reddy's Laboratories (NYSE ... - Seneca Globe (NYSE:RDY)
www.senecaglobe.com - July 27 at 7:27 PM
seekingalpha.com logoDr. Reddy's Laboratories' (RDY) Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NYSE:RDY)
seekingalpha.com - July 27 at 7:27 PM
rttnews.com logoDr Reddy's Laboratories Ltd. Reports 80% Retreat In Q1 Bottom Line (NYSE:RDY)
www.rttnews.com - July 27 at 10:08 AM
4-traders.com logoDr Reddy Laboratories : Doctor Reddy's posts 1Q profit (NYSE:RDY)
www.4-traders.com - July 27 at 10:08 AM
seekingalpha.com logoDr.Reddy's Laboratories revenues off 14% in FQ1 (NYSE:RDY)
seekingalpha.com - July 27 at 10:08 AM
nasdaq.com logoDr. Reddy's Laboratories Breaks Below 200-Day Moving Average - Notable for RDY (NYSE:RDY)
www.nasdaq.com - July 27 at 10:08 AM
fidaily.com logoHSBC Cuts Rating On Dr. Reddy’s Laboratories Ltd Co (RDY) To “Underperform” (NYSE:RDY)
www.fidaily.com - July 27 at 10:08 AM
forbes.com logoDr. Reddy's Laboratories is Now Oversold (RDY) (NYSE:RDY)
www.forbes.com - July 27 at 10:08 AM
finance.yahoo.com logoDr. Reddy's (RDY) Q1 Earnings and Revenues Decline Y/Y (NYSE:RDY)
finance.yahoo.com - July 27 at 9:10 AM
forbes.com logoDr. Reddy's Laboratories is Now Oversold (RDY) - Forbes (NYSE:RDY)
www.forbes.com - July 26 at 7:29 PM
blogs.barrons.com logoDr. Reddy's Tumbles On 1Q Earnings, Venezuela Losses (NYSE:RDY)
blogs.barrons.com - July 26 at 5:49 PM
fool.com logoDr. Reddy's Laboratories Ltd (ADR) Is Tanking Today -- Here's Why (NYSE:RDY)
www.fool.com - July 26 at 4:26 PM
investornewswire.com logoCan Shares Of Dr. Reddy's Laboratories Ltd (NYSE:RDY) Hit $58.5? - Investor Newswire (NYSE:RDY)
www.investornewswire.com - July 26 at 10:27 AM
capitalcube.com logoDr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 (NYSE:RDY)
www.capitalcube.com - July 26 at 9:26 AM
publicnow.com logoDr. Reddy’s Q1 FY17 Financial Results (NYSE:RDY)
www.publicnow.com - July 26 at 6:28 AM
finance.yahoo.com logoDr Reddy's Labs Q1 profit slumps 75 percent, misses estimates (NYSE:RDY)
in.finance.yahoo.com - July 26 at 5:29 AM
reuters.com logoBUZZ-India's Dr. Reddy's Labs falls ahead of earnings (NYSE:RDY)
in.reuters.com - July 25 at 11:28 AM
News IconFirms and Funds Increasing Their Stake in Dr. Reddy's Laboratories Ltd. (NYSE:RDY) - Engelwood Daily (NYSE:RDY)
www.engelwooddaily.com - July 22 at 6:54 PM
News IconDr.Reddy's Laboratories Ltd (ADR) Stock Is Crashing Now. What To Expect? - Consumer Eagle (NYSE:RDY)
www.consumereagle.com - July 22 at 6:54 PM
News IconInstitutions Increasing Their Positions in Dr. Reddy's Laboratories Ltd. (NYSE:RDY) - Engelwood Daily (NYSE:RDY)
www.engelwooddaily.com - July 21 at 9:56 AM
News IconBullish Gap Up for Dr.Reddy's Laboratories Ltd (ADR) After Better Fundamentals - Consumer Eagle (NYSE:RDY)
www.consumereagle.com - July 21 at 9:56 AM
News IconLong Term Value Play: Dr. Reddy's Laboratories Ltd. (NYSE:RDY) - TGP (NYSE:RDY)
telanaganapress.com - July 20 at 9:55 AM
News IconBuy Dr. Reddy's Laboratories, target Rs 3700: Kunal Bothra (NYSE:RDY)
economictimes.indiatimes.com - July 19 at 7:14 PM
streetinsider.com logoDr. Reddys Labs (RDY) Announces U.S. Launch of Omeprazole and Sodium Bicarbonate Caps - StreetInsider.com (NYSE:RDY)
www.streetinsider.com - July 19 at 8:03 AM
News IconAnalysts Pounding the Table on Shares of Dr. Reddy's Laboratories Ltd. (NYSE:RDY) - TGP (NYSE:RDY)
telanaganapress.com - July 19 at 8:03 AM

Social

Dr. Reddy's Laboratories (NYSE:RDY) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff